Assenagon Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Assenagon Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$861K	Sell	59,403 -77,617	-57%	-$1.05M	﹤0.01%	995
2026 Q1	$1.9M	Buy	+137,020	New	+$1.91M	﹤0.01%	784
2024 Q3	–	Sell	-300,240	Closed	-$4.58M	–	1457
2024 Q2	$4.58M	Sell	300,240 -501,020	-63%	-$7.18M	0.01%	654
2024 Q1	$11.8M	Sell	801,260 -179,470	-18%	-$2.62M	0.03%	387
2023 Q4	$13.6M	Buy	980,730 +790,705	+416%	+$10.6M	0.04%	379
2023 Q3	$2.54M	Sell	190,025 -643,310	-77%	-$8.7M	0.01%	770
2023 Q2	$10.5M	Sell	833,335 -409,745	-33%	-$4.78M	0.04%	351
2023 Q1	$14.2M	Buy	1,243,080 +262,890	+27%	+$2.84M	0.05%	310
2022 Q4	$10.1M	Buy	980,190 +664,585	+211%	+$7.17M	0.04%	374
2022 Q3	$3.3M	Buy	+315,605	New	+$3.36M	0.01%	579

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Assenagon Asset Management's RDY Position: Q2 2026 in Review

Assenagon Asset Management reduced its Dr. Reddy's Laboratories (RDY) stake by 57% in Q2 2026, selling an estimated $1.05M and leaving 59,403 shares worth $861K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Assenagon Asset Management first reported a position in RDY in Q3 2022 and has held it in 10 quarters since. The position peaked at $14.2M in Q1 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Assenagon Asset Management held 59,403 shares of Dr. Reddy's Laboratories worth $861K as of Q2 2026.
Assenagon Asset Management sold 77,617 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.05M.
Dr. Reddy's Laboratories made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #995 holding.
Assenagon Asset Management first reported a position in Dr. Reddy's Laboratories in Q3 2022 and has held it in 10 quarters since.
Assenagon Asset Management's Dr. Reddy's Laboratories position peaked at $14.2M in Q1 2023.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.